Selective Binding to mRNA Duplex Regions by Chemically Modified

Nov 8, 2017 - (7, 10, 17, 29, 30, 32, 33, 37, 38) In addition, development of site-specific RNA-binding ligands may facilitate a deeper understanding ...
0 downloads 10 Views 24MB Size
Subscriber access provided by UNIVERSITY OF ADELAIDE LIBRARIES

Article

Selective Binding to mRNA Duplex Regions by Chemically Modified PNAs Stimulates Ribosomal Frameshifting Ru Ying Puah, Huan Jia, Manikantha Maraswami, Desiree-Faye Kaixin Toh, Rya Ero, Lixia Yang, Kiran M. Patil, Alan Ann Lerk Ong, Manchugondanahalli S. Krishna, Ruimin Sun, Cailing Tong, Mei Huang, Xin Chen, Teck-Peng Loh, Yonggui Gao, Ding Xiang Liu, and Gang Chen Biochemistry, Just Accepted Manuscript • DOI: 10.1021/acs.biochem.7b00744 • Publication Date (Web): 08 Nov 2017 Downloaded from http://pubs.acs.org on November 9, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Biochemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Selective Binding to mRNA Duplex Regions by Chemically Modified PNAs Stimulates Ribosomal Frameshifting

Ru Ying Puah,†,1 Huan Jia,†,1 Manikantha Maraswami,†,1 Desiree-Faye Kaixin Toh,†,1 Rya Ero,‡,1 Lixia Yang,† Kiran M. Patil,† Alan Ann Lerk Ong,† Manchugondanahalli S. Krishna,† Ruimin Sun,⊥ Cailing Tong,† Mei Huang,‡ Xin Chen,⊥ Teck Peng Loh,† Yong-Gui Gao,‡ Ding Xiang Liu,‡, #,* and Gang Chen†,*



Division of Chemistry and Biological Chemistry, School of Physical and Mathematical

Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371 ‡

School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive,

Singapore 637551 ⊥

Division of Mathematical Sciences, School of Physical and Mathematical Sciences,

Nanyang Technological University, 21 Nanyang Link, Singapore 637371 #

South China Agricultural University, Guangdong Province Key Laboratory Microbial

Signals & Disease Co, and Integrative Microbiology Research Centre, Guangzhou 510642, Guangdong, People’s Republic of China.

Corresponding Authors: Emails: [email protected] or [email protected] 1

These authors contributed equally to this work. 1 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 36

Abstract Minus-one programmed ribosomal frameshifting (–1 PRF) allows the precise maintenance of the ratio between viral proteins, and is involved in the regulation of the half-lives of cellular mRNAs. Minus-one ribosomal frameshifting (–1 RF) is activated by several stimulatory elements such as a heptameric slippery sequence (X XXY YYZ) and an mRNA secondary structure (hairpin or pseudoknot) that is positioned 2-8 nucleotides downstream from the slippery site. Upon –1 RF, the ribosomal reading frame is shifted from the normal zero frame to the –1 frame with the heptameric slippery sequence decoded as XXX YYY Z instead of X XXY YYZ. Our research group has developed chemically-modified Peptide Nucleic Acid (PNA) L and Q monomers to recognize G-C and C-G Watson–Crick base pairs, respectively, through major-groove parallel PNA·RNA-RNA triplex formation. L- and Q-incorporated PNAs show selective binding to double-stranded RNAs (dsRNAs) over single-stranded RNAs (ssRNAs). The sequence specificity and structural selectivity of L- and Q-modified PNAs may allow the precise targeting of desired viral and cellular RNA structures, and thus may serve as valuable biological tools for mechanistic studies and potential therapeutics for fighting diseases. Here, for the first time, we demonstrate by cell-free in vitro translation assays using rabbit reticulocyte lysate that the dsRNA-specific chemically-modified PNAs targeting model mRNA hairpins stimulate –1 RF (from 2% to 32%). An unmodified control PNA, however, shows nonspecific inhibition of translation. Our results suggest that the modified dsRNA-binding PNAs may be advantageous for targeting structured RNAs.

2 ACS Paragon Plus Environment

Page 3 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Introduction Minus-one programmed ribosomal frameshifting (–1 PRF) is a translational recoding mechanism that is employed by many viruses and organisms ranging from prokaryotes to higher eukaryotes.1-3 Minus-one ribosomal frameshifting (–1 RF) is activated by a heptameric slippery sequence (X XXY YYZ) and an mRNA secondary structure that is positioned 2-8 nucleotides (nt) downstream from the slippery site. In viruses and eukaryotes, X, Y, and Z are usually any bases, A or U, and non-G bases, respectively.1 The ribosomal reading frame is shifted, upon –1 RF, from a normal zero frame to a –1 frame with the two codons at the slippery site decoded as XXX and YYY, respectively, instead of XXY and YYZ (Figure 1a). Previous research suggests that –1 RF at a slippery site may be stimulated by a downstream hairpin, pseudoknot, G-quadruplex, or a duplex formed between an antisense oligonucleotide and mRNA.4-17 A downstream mRNA secondary structure causes blockage at the entrance of the mRNA tunnel, hampering the rotation of the ribosomal subunits with respect to each other and therefore, promotes the backward movement of the ribosome by one nucleotide at the slippery site.2, 3, 18-24 Minus-one PRF is often highly regulated with a narrow window of recoding efficiency for a specific virus (e.g., 5% for HIV-1), which allows the precise maintenance of the ratio between viral proteins.2, 3, 25 Either decreasing or increasing the –1 RF may affect viral replication. For example, HIV-1 mutants with an enhanced –1 RFstimulatory mRNA hairpin local stability and thus –1 RF efficiencies are significantly less infectious.26 In addition to being essential for the replication of many viruses, –1 RF is also involved in the regulation of the half-lives of cellular mRNAs.2, 27

The cis-acting –1 RF-stimulatory viral mRNA hairpin or pseudoknot structures are often highly conserved, and thus, are potential target sites for the regulation of –1 RF.28-33 The 3 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 36

structural stability of the mRNA secondary structures may be critical for stimulating –1 RF.4, 26, 34-36

Thus, RNA structure-binding ligands may be developed to modulate the structural

stability and –1 RF efficiency.7, 10, 17, 29, 30, 32, 33, 37, 38 In addition, development of site-specific RNA-binding ligands may facilitate a deeper understanding of the complex –1 RF processes. For example, viral mRNA pseudoknots found in beet western yellows virus (BWYV) and murine leukaemia virus (MLV) show protonation dependent pseudoknot structure stabilization, with the fraction of a protonated C or A residue (with near-neutral pKa values and corresponding binding affinities of µM) correlates with the frequency of the translational recoding events.38 Small molecule ligand binding (with binding affinity on the order of nM to µM) to riboswitch aptamer structure also stimulates –1 RF, presumably through the stabilization of the riboswitch aptamer structures.7, 17

Peptide Nucleic Acid (PNA) is a type of artificial nucleic acid, which consists of an uncharged 2-aminoethyl glycine unit instead of the phosphodiester backbone, and a methylene carbonyl linker instead of a cyclic sugar moiety (Figure 2).39-46 PNA’s non-ionic and flexible backbone allows it to form Watson–Crick duplexes with a complementary RNA or DNA in both parallel and antiparallel manners, with significantly enhanced stability compared to DNA/RNA duplexes. Furthermore, PNA has a lower sensitivity towards ionic strength changes, and is resistant to nucleases and proteases.45 Thus, there is a great potential in developing PNAs as chemical probes and potential therapeutic agents.

4 ACS Paragon Plus Environment

Page 5 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 1. Scheme of p2luc dual-luciferase system and PNAs for in vitro translation assays. (a) Experimental mRNA constructs with the insertion between the RLuc and FLuc genes of three model sequences: RNA hairpin 1 (rHP1), ssRNA, and rHP2. The slippery sequence (U UUU UUA) is the same as that found at the HIV-1 frameshift site and is underlined. The 0 frame stop codon (UAG) is shown in orange. Minus-one RF results in the production of both RLuc (0 frame) and FLuc (–1 frame) proteins. The PNA sequences aligned with the targeted regions of the mRNAs are shown. For free rHP1 and rHP2, the hairpin stem is located three nucleotides downstream of the slippery sequence. The PNA·RNA-RNA triplexes, however, are located eight nucleotides downstream of the slippery sequence. An 8-nt spacer is found at the HIV-1 frameshift site. (b) mRNA constructs serving as positive controls for 100% –1 RF efficiency. The control mRNA constructs contain the same hairpins (rHP1 and rHP2) or ssRNA as indicated. The slippery sequences were mutated (indicated by green color) so as to have non-slippery sequences and to have FLuc translated in 0 frame.

5 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 36

Figure 2. Chemical structures of stable PNA·RNA-RNA base triples and unstable PNA-RNA base pairs. The letter “R” indicates the sugar-phosphate backbone of RNA. (a-d) Chemical structures of triples C+·G-C, T·A-U, L·G-C, and Q·C-G. (e,f) Unstable Watson–Crick-like base pairs of L-G and Q-G.

6 ACS Paragon Plus Environment

Page 7 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Table 1. Sequences of synthesized PNAs and the previously reported47, 48 RNA-binding properties.

PNA Sequence

Tm (°C) (parallel duplex)a

Tm (°C) (antiparallel duplex)a

KD (µM) binding to rHP1b

KD (µM) binding to rHP2b

P3

NH2-Lys-TLTQTTTL-CONH2

10 µM, we observed non-specific inhibition of translation (see Figure S2).

14 ACS Paragon Plus Environment

Page 15 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 4. Effects of PNAs on the expression of FLuc and RLuc. The expression levels are normalized. (a) PNA P3 selectively enhances the expression of FLuc of the experimental mRNA rHP2 construct. (b) PNA P5 selectively enhances the expression of FLuc of the experimental mRNA rHP1 construct. (c) Unmodified PNA P1 shows non-selective inhibition of the expression of both FLuc and RLuc. (d,e) Plots of normalized FLuc and RLuc expression levels versus fractions of mRNA hairpin bound by dsRNA-binding PNA. The fraction of mRNA hairpin bound by PNA is calculated assuming the binding reaches an equilibrium.

15 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 16 of 36

We tested if pre-incubation of PNA with mRNA would affect the efficacy of –1 RF stimulation. We observed that even without the 20-min pre-incubation, P3 and P5 are still able to induce –1 RF of rHP2 and rHP1, respectively (Figure S3). The results are consistent with the fact that PNA·RNA-RNA triplex formation is relatively fast,59,

60

and the two

modified PNAs (P3 and P5) activate –1 RF during the multiple turnovers of translation elongation. We also tested if the PNAs affect the activities of the luciferases by adding the PNAs after the translation reactions were completed. For all the mRNAs, upon the posttranslational addition of the PNAs (modified PNAs P3 and P5 and unmodified PNA P1), we observed no significant changes in the –1 RF efficiency (Figure S4), and the expression levels of RLuc and FLuc (Figure S5). Thus, the unmodified and modified PNAs show no direct effect on the luciferase activities. Taken together, our results verify that the changes in –1 RF efficiency (Figure 3) result from the specific interactions between the mRNA hairpins and the dsRNA-binding modified PNAs (Figure 1).

Unmodified PNAs are known to be able to bind to complementary ssRNAs and partially structured RNAs through strand invasion.61 Thus, compared to our chemically-modified PNAs, unmodified PNAs may show less selectivity and specificity in binding to structured RNAs. For example, the unmodified PNA P1 (Figure 1) can bind to rHP1 (Figure 2a,b, Table 1).47,

48

In addition, PNA P1 can form parallel and antiparallel duplexes with 5ʹ-

AGAGAAAG-3ʹ and 3ʹ-AGAGAAAG-5ʹ, respectively (Table 1). PNA P1, however, shows no binding to rHP2 (Table 1). We tested the effect of PNA P1 on –1 RF. As illustrated in Figure 4c, for all mRNAs (ssRNA, rHP1, and rHP2), with increasing concentration of unmodified PNA P1 added, the expression levels of both FLuc and RLuc drop significantly to baseline level. It is possible that PNA P1 inhibits translation by binding to rRNAs and/or coding regions of Renilla/firefly luciferase genes. By examining the sequences of Homo 16 ACS Paragon Plus Environment

Page 17 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

sapiens ribosomal RNAs (rRNAs) (similar to rabbit rRNAs)62 and p2luc vector, several possible off-target sites containing sequences similar to 5ʹ-AGAGAAAG-3ʹ and 3ʹAGAGAAAG-5ʹ were identified (Figure 5 and Appendix in Supporting Information). We used the secondary structures of human rRNAs because (i) the secondary structure of the large subunit rabbit rRNA is not available,62 (ii) human rRNAs are very similar to rabbit rRNAs, and (iii) the near-atomic resolution structure of the human ribosome has recently become available.63, 64

Out of the three predicted binding regions in 18S rRNA (Figure 5), two (HS1 and HS3) are buried within the 40S subunit and likely not accessible to P1 PNA (Figure S6). In contrast, HS2 region is located at the back of 40S neck and almost entirely exposed to solvent (Figure 6a and Figure S6) making it a likely binding site for PNA P1. Given that the dynamics (rolling and swiveling of 40S head) of the neck region is highly important for the efficiency and fidelity of translocation, P1 PNA interaction with HS2 region could explain the nonspecific inhibition of translation.

The potential P1 PNA binding sites (six altogether) of 28S rRNA (Figure 5) exhibit varied structural contexts in ribosome (Figure S6). While the HL1 region is not far from GTPase activation site of the ribosome, it is buried within 60S subunit. In contrast, HL2 region is solvent accessible yet far away from ribosomal regions directly linked to translation. Another potential P1 binding site, HL5, while surrounded by 60S structure, is located close to 40S in a region likely involved in inter-subunit communication during translation.

17 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 18 of 36

Figure 5. Potential off-target binding sites of unmodified PNA P1 in homo sapiens rRNAs. The identified sequences are similar to RNA 5ʹ-AGAGAAAG-3ʹ (shown in red) or RNA 3ʹAGAGAAAG-5ʹ (shown in blue) and may form parallel or antiparallel PNA-RNA duplexes with unmodified PNA P1, respectively.

18 ACS Paragon Plus Environment

Page 19 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Curiously, three regions (HL3, HL4, and HL6) are located in the vicinity of the nascent peptide exit tunnel and are at least partially accessible to PNA P1 (Figure 6b,c and Figure S6). HL3 region is located adjacent to the tunnel exit on solvent side of 60S, and PNA P1 binding could affect trans factors involved in nascent protein folding or transport. HL4 aligns the inside of the tunnel, with the tunnel diameter of 15-20 Å. Thus, even with PNA bound, there is likely enough room for peptide chain to pass. However the dynamic interactions with the tunnel are believed to facilitate protein folding, so the effect could be more indirect. HL6 is situated close to the tunnel entrance as well as the peptidyl transferase center at the subunit interface side (Figure 6b,c). The diameter of the ribosome exit tunnel in the vicinity of HL6 is about 10 Å. Thus, PNA binding to HL6 could physically hinder nascent chain proceeding through the tunnel, as this part is the narrowest region of the tunnel and even small molecules like antibiotics are known to affect nascent chain tunnel interactions. Furthermore, HL6 region is likely involved in the stabilization of 28S rRNA U4452 residue (Figure 6b) that has been proposed63 to function as a gatekeeper to correctly orient the early growing nascent peptide.

Taken together, it is highly probable that the nonspecific inhibition of translation by P1 is due to duplex formation between P1 and the identified rRNA regions, resulting in the obstruction of ribosomal functions.65, 66 In addition, binding of P1 to the coding regions of RLuc gene (see Appendix in Supporting Information) may affect the ribosomal translocation on mRNA. Thus, for the PNAs tested here, the chemically-modified dsRNA-binding PNAs show more specific binding with reduced off-target binding.

19 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 20 of 36

Figure 6. Potential binding sites of unmodified PNA P1 in human ribosome 3D structure. Predicted P1 PNA binding sites were mapped onto H. sapiens 80S ribosome structure solved by cryo-electron microscopy (PDB ID: 5T2C).64 Figures were generated using PyMol Molecular Graphics System, Schrödinger, LLC. (a) Close-up view (from the 40S solvent side) of the 18S rRNA HS2 sequence predicted to interact with P1 PNA. HS2 sequence is shown in red sticks. 40S proteins in the vicinity of HS2 are indicated. SA stands for 40S ribosomal protein SA. (b,c) Close-up views of the 28S rRNA HL6, HL4, and HL3 sequences (shown in red sticks) predicted to interact with P1 PNA from the 60S intersubunit and solvent side, respectively. 28S rRNA U4452 residue located at the entrance of the nascent peptide exit tunnel is shown in magenta sticks. 5.8S rRNA is shown in yellow cartoon. 60S proteins in the vicinity of predicted P1 binding rRNA sequences are also indicated. Asterisk marks the nascent peptide exit tunnel through the 60S subunit.

The identified potential binding sites in rRNAs for the unmodified PNA P1 are essentially single-stranded, and may not be recognized by chemically-modified PNAs P3 and P5 because P3 and P5 show selective binding towards dsRNAs over ssRNAs (Table 1).47 Consistently, a less prominent reduction was observed in the RLuc readings upon the addition of P3 and P5 (Figure 4). Our data indicate that chemically-modified PNAs P3 and P5 site-specifically bind to rHP2 and rHP1, respectively, with reduced off-target binding to ribosome or other regions of mRNA.

20 ACS Paragon Plus Environment

Page 21 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

To rule out the possibility that mRNAs degrade upon the addition of PNAs, we carried out agarose gel electrophoresis of the model mRNAs in the absence and presence of PNAs. The gel results reveal no mRNA degradation upon the incubation with the PNAs (P3, P5, and P1) (Figure S1). Taken together, our results suggest that, compared to unmodified PNAs, the Qand L-modified dsRNA-binding PNAs are superior in sequence-specifically and selectively targeting the dsRNA regions of structured RNAs.

Conclusions In summary, our results suggest that relatively short chemically-modified dsRNA-binding PNAs may be used to probe the complex ribosomal translation processes. Formation of a major-groove parallel PNA·RNA-RNA triplex may stimulate –1 RF due to the stabilization of mRNA duplex structures, and/or the interference of the direct interactions of mRNA duplex at the entrance tunnel with the ribosome at the slippery site. The chemically-modified PNAs platform may be applied in future to the targeting of viral RNA structures to uncover the roles of cis-acting mRNA structures in stimulating –1 PRF. To allow the production of a protein in the downstream –1 frame, the PNA·RNA-RNA triplex needs to be unwound for continued translation in –1 frame. It is known that an overly stable mRNA structure may block translation instead of stimulate –1 RF.67 Thus, we expect that the stimulation of –1 RF and other translational regulations will be highly dependent on the sequence, length, and binding position of the dsRNA-binding PNAs. Future structural and mechanistic studies will help develop dsRNA-binding PNAs with further improved efficacy and selectivity in stimulating –1 RF. Our work also provides insights into future development of highly selective and potent PNAs targeting rRNA structures. With the advances in PNA delivery technologies,47, 68-79 our work on the model mRNAs may also serve as a basis for the future 21 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 22 of 36

development of antivirals targeting viral mRNA structures that stimulate –1 PRF, and therapeutics targeting many other biomedically-important RNAs.

Associated Content Supporting Information The Supporting Information is available free of charge on the ACS Publications website. Detailed experimental protocols and list of DNA oligonucleotides used. Agarose gel data (Figure S1), Nonspecific inhibition of translation observed for PNAs P3 and P5 at > 10 µM (Figure S2), frameshifting assay data without mRNA-PNA pre-incubation (Figure S3), minus-one RF efficiency data with PNAs added after the in vitro translation reactions (Figure S4), relative RLuc and FLuc activities with the PNAs added after the in vitro translation reactions (Figure S5), overview of the distribution and location of the putative P1 PNA binding sites in the ribosome (Figure S6), detailed sequences of the plasmids containing segments similar to 5ʹ-AGAGAAAG-3ʹ and 3ʹ-AGAGAAAG-5ʹ, and secondary structures of rRNAs.

Author Information Corresponding Authors [email protected] and [email protected] ORCID: Gang Chen: 0000-0002-8772-9755 Notes 22 ACS Paragon Plus Environment

Page 23 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

The authors declare no competing financial interest.

Acknowledgement This work was supported by the grants from Singapore Ministry of Education (MOE) Tier 1 (RGT3/13 and RG42/15 to G.C.) and MOE Tier 2 (MOE2013-T2-2-024 and MOE2015-T21-028 to G.C., and MOE2014-T2-1-083 to Y.-G.G.). We thank Prof Sam Butcher for sharing the experimental protocols, and for providing the p2luc plasmids which was originally constructed by Profs John Atkins and Raymond Gesteland, Prof Robin Gutell for sharing the secondary structures of rRNAs, and Prof Rene Olsthoorn for critically reading the manuscript.

References

[1] Farabaugh, P. J. (1996) Programmed translational frameshifting, Microbiol. Rev. 60, 103134. [2] Dinman, J. D. (2012) Mechanisms and implications of programmed translational frameshifting, Wiley Interdiscip. Rev. RNA 3, 661-673. [3] Caliskan, N., Peske, F., and Rodnina, M. V. (2015) Changed in translation: mRNA recoding by -1 programmed ribosomal frameshifting, Trends Biochem. Sci. 40, 265274. [4] Mouzakis, K. D., Lang, A. L., Vander Meulen, K. A., Easterday, P. D., and Butcher, S. E. (2013) HIV-1 frameshift efficiency is primarily determined by the stability of base pairs positioned at the mRNA entrance channel of the ribosome, Nucleic Acids Res. 41, 1901-1913. [5] Olsthoorn, R. C., Reumerman, R., Hilbers, C. W., Pleij, C. W., and Heus, H. A. (2010) Functional analysis of the SRV-1 RNA frameshifting pseudoknot, Nucleic Acids Res. 38, 7665-7672. [6] Chen, G., Chang, K. Y., Chou, M. Y., Bustamante, C., and Tinoco, I., Jr. (2009) Triplex structures in an RNA pseudoknot enhance mechanical stability and increase efficiency of -1 ribosomal frameshifting, Proc. Natl. Acad. Sci. U. S. A. 106, 12706-12711. [7] Chou, M. Y., Lin, S. C., and Chang, K. Y. (2010) Stimulation of -1 programmed ribosomal frameshifting by a metabolite-responsive RNA pseudoknot, RNA 16, 12361244. [8] Su, M. C., Chang, C. T., Chu, C. H., Tsai, C. H., and Chang, K. Y. (2005) An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1 ribosomal frameshifting of SARS coronavirus, Nucleic Acids Res. 33, 4265-4275. 23 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 24 of 36

[9] Zhong, Z., Yang, L., Zhang, H., Shi, J., Vandana, J. J., Lam, D. T., Olsthoorn, R. C., Lu, L., and Chen, G. (2016) Mechanical unfolding kinetics of the SRV-1 gag-pro mRNA pseudoknot: possible implications for -1 ribosomal frameshifting stimulation, Sci. Rep. 6, 39549. [10] Chen, Y. T., Chang, K. C., Hu, H. T., Chen, Y. L., Lin, Y. H., Hsu, C. F., Chang, C. F., Chang, K. Y., and Wen, J. D. (2017) Coordination among tertiary base pairs results in an efficient frameshift-stimulating RNA pseudoknot, Nucleic Acids Res. 45, 60116022. [11] Endoh, T., and Sugimoto, N. (2013) Unusual -1 ribosomal frameshift caused by stable RNA G-quadruplex in open reading frame, Anal. Chem. 85, 11435-11439. [12] Yu, C. H., Teulade-Fichou, M. P., and Olsthoorn, R. C. (2014) Stimulation of ribosomal frameshifting by RNA G-quadruplex structures, Nucleic Acids Res. 42, 1887-1892. [13] Olsthoorn, R. C. L., Laurs, M., Sohet, F., Hilbers, C. W., Heus, H. A., and Pleij, C. W. A. (2004) Novel application of sRNA: Stimulation of ribosomal frameshifting, RNA 10, 1702-1703. [14] Yu, C. H., Noteborn, M. H., and Olsthoorn, R. C. (2010) Stimulation of ribosomal frameshifting by antisense LNA, Nucleic Acids Res. 38, 8277-8283. [15] Henderson, C. M., Anderson, C. B., and Howard, M. T. (2006) Antisense-induced ribosomal frameshifting, Nucleic Acids Res. 34, 4302-4310. [16] Howard, M. T., Gesteland, R. F., and Atkins, J. F. (2004) Efficient stimulation of sitespecific ribosome frameshifting by antisense oligonucleotides, RNA 10, 1653-1661. [17] Yu, C. H., Luo, J., Iwata-Reuyl, D., and Olsthoorn, R. C. (2013) Exploiting preQ1 riboswitches to regulate ribosomal frameshifting, ACS Chem. Biol. 8, 733-740. [18] Chen, J., Petrov, A., Johansson, M., Tsai, A., O'Leary, S. E., and Puglisi, J. D. (2014) Dynamic pathways of -1 translational frameshifting, Nature 512, 328-332. [19] Frank, J., Gao, H., Sengupta, J., Gao, N., and Taylor, D. J. (2007) The process of mRNA-tRNA translocation, Proc. Natl. Acad. Sci. U. S. A. 104, 19671-19678. [20] Chen, C., Zhang, H., Broitman, S. L., Reiche, M., Farrell, I., Cooperman, B. S., and Goldman, Y. E. (2013) Dynamics of translation by single ribosomes through mRNA secondary structures, Nat Struct Mol Biol 20, 582-588. [21] Kim, H. K., Liu, F., Fei, J., Bustamante, C., Gonzalez, R. L., Jr., and Tinoco, I., Jr. (2014) A frameshifting stimulatory stem loop destabilizes the hybrid state and impedes ribosomal translocation, Proc. Natl. Acad. Sci. U. S. A. 111, 5538-5543. [22] Caliskan, N., Katunin, V. I., Belardinelli, R., Peske, F., and Rodnina, M. V. (2014) Programmed -1 frameshifting by kinetic partitioning during impeded translocation, Cell 157, 1619-1631. [23] Yan, S., Wen, J. D., Bustamante, C., and Tinoco, I., Jr. (2015) Ribosome excursions during mRNA translocation mediate broad branching of frameshift pathways, Cell 160, 870-881. [24] Qin, P., Yu, D., Zuo, X., and Cornish, P. V. (2014) Structured mRNA induces the ribosome into a hyper-rotated state, EMBO Rep 15, 185-190. [25] Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., and Varmus, H. E. (1988) Characterization of ribosomal frameshifting in HIV-1 Gag-Pol expression, Nature 331, 280-283. [26] Garcia-Miranda, P., Becker, J. T., Benner, B. E., Blume, A., Sherer, N. M., and Butcher, S. E. (2016) Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity, J Virol 90, 6906-6917. [27] Belew, A. T., Meskauskas, A., Musalgaonkar, S., Advani, V. M., Sulima, S. O., Kasprzak, W. K., Shapiro, B. A., and Dinman, J. D. (2014) Ribosomal frameshifting

24 ACS Paragon Plus Environment

Page 25 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

in the CCR5 mRNA is regulated by miRNAs and the NMD pathway, Nature 512, 265-269. [28] Dinman, J. D., Ruiz-Echevarria, M. J., and Peltz, S. W. (1998) Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents, Trends in Biotechnology 16, 190-196. [29] Marcheschi, R. J., Mouzakis, K. D., and Butcher, S. E. (2009) Selection and characterization of small molecules that bind the HIV-1 frameshift site RNA, ACS Chem. Biol. 4, 844-854. [30] Gareiss, P. C., and Miller, B. L. (2009) Ribosomal frameshifting: An emerging drug target for HIV, Curr. Opin. Invest. Drugs 10, 121-128. [31] Giedroc, D. P., and Cornish, P. V. (2009) Frameshifting RNA pseudoknots: Structure and mechanism, Virus Res. 139, 193-208. [32] Brakier-Gingras, L., Charbonneau, J., and Butcher, S. E. (2012) Targeting frameshifting in the human immunodeficiency virus, Expert Opin. Ther. Targets 16, 249-258. [33] Hilimire, T. A., Bennett, R. P., Stewart, R. A., Garcia-Miranda, P., Blume, A., Becker, J., Sherer, N., Helms, E. D., Butcher, S. E., Smith, H. C., and Miller, B. L. (2016) NMethylation as a strategy for enhancing the affinity and selectivity of RNA-binding peptides: Application to the HIV-1 frameshift-stimulating RNA, ACS Chem. Biol. 11, 88-94. [34] Liphardt, J., Napthine, S., Kontos, H., and Brierley, I. (1999) Evidence for an RNA pseudoknot loop-helix interaction essential for efficient -1 ribosomal frameshifting, J. Mol. Biol. 288, 321-335. [35] Namy, O., Moran, S. J., Stuart, D. I., Gilbert, R. J., and Brierley, I. (2006) A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting, Nature 441, 244-247. [36] Zhang, X., Xu, X., Yang, Z., Burcke, A. J., Gates, K. S., Chen, S. J., and Gu, L. Q. (2015) Mimicking ribosomal unfolding of RNA pseudoknot in a protein channel, J. Am. Chem. Soc. 137, 15742-15752. [37] Chou, M. Y., and Chang, K. Y. (2010) An intermolecular RNA triplex provides insight into structural determinants for the pseudoknot stimulator of -1 ribosomal frameshifting, Nucleic Acids Res. 38, 1676-1685. [38] Houck-Loomis, B., Durney, M. A., Salguero, C., Shankar, N., Nagle, J. M., Goff, S. P., and D'Souza, V. M. (2011) An equilibrium-dependent retroviral mRNA switch regulates translational recoding, Nature 480, 561-564. [39] Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules, Nature 365, 566-568. [40] Nielsen, P. E., Egholm, M., and Buchardt, O. (1994) Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone, Bioconjugate Chem. 5, 3-7. [41] Wittung, P., Nielsen, P. E., Buchardt, O., Egholm, M., and Norden, B. (1994) DNA-like double helix formed by peptide nucleic acid, Nature 368, 561-563. [42] Hyrup, B., and Nielsen, P. E. (1996) Peptide nucleic acids (PNA): Synthesis, properties and potential applications, Bioorg Med Chem 4, 5-23. [43] Eriksson, M., and Nielsen, P. E. (1996) PNA-nucleic acid complexes. Structure, stability and dynamics, Q Rev Biophys 29, 369-394. [44] Nielsen, P. E., and Egholm, M. (1999) An introduction to peptide nucleic acid, Curr Issues Mol Biol 1, 89-104. [45] Ray, A., and Norden, B. (2000) Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future, FASEB J. 14, 1041-1060. 25 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 26 of 36

[46] Jarver, P., O'Donovan, L., and Gait, M. J. (2014) A chemical view of oligonucleotides for exon skipping and related drug applications, Nucleic Acid Ther. 24, 37-47. [47] Toh, D. K., Devi, G., Patil, K. M., Qu, Q., Maraswami, M., Xiao, Y., Loh, T. P., Zhao, Y., and Chen, G. (2016) Incorporating a guanidine-modified cytosine base into triplex-forming PNAs for the recognition of a C-G pyrimidine-purine inversion site of an RNA duplex, Nucleic Acids Res. 44, 9071-9082. [48] Devi, G., Yuan, Z., Lu, Y. P., Zhao, Y. L., and Chen, G. (2014) Incorporation of thiopseudoisocytosine into triplex-forming peptide nucleic acids for enhanced recognition of RNA duplexes, Nucleic Acids Res. 42, 4008-4018. [49] Zhou, P., Wang, M., Du, L., Fisher, G. W., Waggoner, A., and Ly, D. H. (2003) Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA), J. Am. Chem. Soc. 125, 6878-6879. [50] Gupta, P., Muse, O., and Rozners, E. (2012) Recognition of double-stranded RNA by guanidine-modified peptide nucleic acids, Biochemistry 51, 63-73. [51] Moccia, M., Adamo, M. F., and Saviano, M. (2014) Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity, Artif. DNA PNA XNA 5, e1107176. [52] Devi, G., Zhou, Y., Zhong, Z., Toh, D.-F. K., and Chen, G. (2015) RNA triplexes: From structural principles to biological and biotech applications, Wiley Interdiscip. Rev. RNA 6, 111-128. [53] Patil, K. M., and Chen, G. (2016) Recognition of RNA sequence and structure by duplex and triplex formation: Targeting miRNA and pre-miRNA, In Modified Nucleic Acids in Biology and Medicine (Jurga, S., Erdmann, V. A., and Barciszewski, J., Eds.), pp 299-317, Springer International Publishing. [54] Toh, D. K., Patil, K. M., and Chen, G. (2017) Sequence-specific and selective recognition of double-stranded RNAs over single-stranded RNAs by chemically modified peptide nucleic acids, J. Vis. Exp. 127, e56221. [55] Vilaivan, T. (2015) Pyrrolidinyl PNA with alpha/beta-Dipeptide Backbone: From Development to Applications, Acc. Chem. Res. 48, 1645-1656. [56] Grentzmann, G., Ingram, J. A., Kelly, P. J., Gesteland, R. F., and Atkins, J. F. (1998) A dual-luciferase reporter system for studying recoding signals, RNA 4, 479-486. [57] Lin, Z., Gilbert, R. J., and Brierley, I. (2012) Spacer-length dependence of programmed 1 or -2 ribosomal frameshifting on a U6A heptamer supports a role for messenger RNA (mRNA) tension in frameshifting, Nucleic Acids Res. 40, 8674-8689. [58] Yu, C. H., Noteborn, M. H., Pleij, C. W., and Olsthoorn, R. C. (2011) Stem-loop structures can effectively substitute for an RNA pseudoknot in -1 ribosomal frameshifting, Nucleic Acids Res. 39, 8952-8959. [59] Sato, T., Sato, Y., and Nishizawa, S. (2016) Triplex-forming peptide nucleic acid probe having thiazole orange as a base surrogate for fluorescence sensing of doublestranded RNA, J. Am. Chem. Soc. 138, 9397-9400. [60] Endoh, T., Hnedzko, D., Rozners, E., and Sugimoto, N. (2016) Nucleobase-modified PNA suppresses translation by forming a triple helix with a hairpin structure in mRNA in vitro and in cells, Angew. Chem. In.t Ed. Engl. 55, 899-903. [61] Armitage, B. A. (2003) The impact of nucleic acid secondary structure on PNA hybridization, Drug Discov. Today 8, 222-228. [62] Cannone, J. J., Subramanian, S., Schnare, M. N., Collett, J. R., D'Souza, L. M., Du, Y., Feng, B., Lin, N., Madabusi, L. V., Muller, K. M., Pande, N., Shang, Z., Yu, N., and Gutell, R. R. (2002) The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs, BMC Bioinformatics 3, 2. 26 ACS Paragon Plus Environment

Page 27 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

[63] Khatter, H., Myasnikov, A. G., Natchiar, S. K., and Klaholz, B. P. (2015) Structure of the human 80S ribosome, Nature 520, 640-U338. [64] Zhang, X., Lai, M., Chang, W., Yu, I., Ding, K., Mrazek, J., Ng, H. L., Yang, O. O., Maslov, D. A., and Zhou, Z. H. (2016) Structures and stabilization of kinetoplastidspecific split rRNAs revealed by comparing leishmanial and human ribosomes, Nat. Commun. 7, 13223. [65] Auerbach-Nevo, T., Baram, D., Bashan, A., Belousoff, M., Breiner, E., Davidovich, C., Cimicata, G., Eyal, Z., Halfon, Y., Krupkin, M., Matzov, D., Metz, M., Rufayda, M., Peretz, M., Pick, O., Pyetan, E., Rozenberg, H., Shalev-Benami, M., Wekselman, I., Zarivach, R., Zimmerman, E., Assis, N., Bloch, J., Israeli, H., Kalaora, R., Lim, L., Sade-Falk, O., Shapira, T., Taha-Salaime, L., Tang, H., and Yonath, A. (2016) Ribosomal antibiotics: Contemporary challenges, Antibiotics 5, 24. [66] Kulik, M., Markowska-Zagrajek, A., Wojciechowska, M., Grzela, R., Witula, T., and Trylska, J. (2017) Helix 69 of Escherichia coli 23S ribosomal RNA as a peptide nucleic acid target, Biochimie 138, 32-42. [67] Tholstrup, J., Oddershede, L. B., and Sorensen, M. A. (2012) mRNA pseudoknot structures can act as ribosomal roadblocks, Nucleic Acids Res. 40, 303-313. [68] Shiraishi, T., and Nielsen, P. E. (2011) Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain, Methods Mol. Biol. 751, 209-221. [69] Shiraishi, T., and Nielsen, P. E. (2012) Nanomolar cellular antisense activity of peptide nucleic acid (PNA) cholic acid ("umbrella") and cholesterol conjugates delivered by cationic lipids, Bioconjugate Chem. 23, 196-202. [70] Torres, A. G., Fabani, M. M., Vigorito, E., Williams, D., Al-Obaidi, N., Wojciechowski, F., Hudson, R. H., Seitz, O., and Gait, M. J. (2012) Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs, Nucleic Acids Res. 40, 2152-2167. [71] Das, I., Desire, J., Manvar, D., Baussanne, I., Pandey, V. N., and Decout, J. L. (2012) A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription, J. Med. Chem. 55, 60216032. [72] Bahal, R., McNeer, N. A., Ly, D. H., Saltzman, W. M., and Glazer, P. M. (2013) Nanoparticle for delivery of antisense gammaPNA oligomers targeting CCR5, Artif. DNA PNA XNA 4, 49-57. [73] Ma, X., Devi, G., Qu, Q., Toh, D. F., Chen, G., and Zhao, Y. (2014) Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles, Bioconjugate Chem. 25, 1412-1420. [74] Avitabile, C., Accardo, A., Ringhieri, P., Morelli, G., Saviano, M., Montagner, G., Fabbri, E., Gallerani, E., Gambari, R., and Romanelli, A. (2015) Incorporation of naked peptide nucleic acids into liposomes leads to fast and efficient delivery, Bioconjugate Chem. 26, 1533-1541. [75] Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., Saltzman, W. M., and Slack, F. J. (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment, Nature 518, 107-110. [76] Gupta, A., Bahal, R., Gupta, M., Glazer, P. M., and Saltzman, W. M. (2016) Nanotechnology for delivery of peptide nucleic acids (PNAs), J. Control. Release 240, 302-311.

27 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 28 of 36

[77] Ellipilli, S., Palvai, S., and Ganesh, K. N. (2016) Fluorinated peptide nucleic acids with fluoroacetyl side chain bearing 5-(F/CF3)-uracil: Synthesis and cell uptake studies, J. Org. Chem. 81, 6364-6373. [78] Hnedzko, D., McGee, D. W., Karamitas, Y. A., and Rozners, E. (2017) Sequenceselective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids, RNA 23, 58-69. [79] Bahal, R., Ali McNeer, N., Quijano, E., Liu, Y., Sulkowski, P., Turchick, A., Lu, Y. C., Bhunia, D. C., Manna, A., Greiner, D. L., Brehm, M. A., Cheng, C. J., LopezGiraldez, F., Ricciardi, A., Beloor, J., Krause, D. S., Kumar, P., Gallagher, P. G., Braddock, D. T., Mark Saltzman, W., Ly, D. H., and Glazer, P. M. (2016) In vivo correction of anaemia in beta-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery, Nat. Commun. 7, 13304.

28 ACS Paragon Plus Environment

Page 29 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

For Table of Contents Use Only

29 ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 1 190x160mm (300 x 300 DPI)

ACS Paragon Plus Environment

Page 30 of 36

Page 31 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 2 190x220mm (300 x 300 DPI)

ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 3 190x145mm (300 x 300 DPI)

ACS Paragon Plus Environment

Page 32 of 36

Page 33 of 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Biochemistry

Figure 4 190x189mm (300 x 300 DPI)

ACS Paragon Plus Environment

Biochemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 5 190x219mm (300 x 300 DPI)

ACS Paragon Plus Environment

Page 34 of 36

Page 35 of 36

(a) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Biochemistry

(b)

ACS Paragon Plus Environment

(c)

60S

Biochemistry

Page 36 of 36 Zero frame

CCU UUU UUA GGG

1 +d ACS Plus Environment sRN bi Paragon 3 Zero frame nding PNAMinus-one frame A CC UUU UUU AGG G 4CCU UUU UUA GGG

2 40S